Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

421093

registered interest
date	13/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Everolimus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what timetable NHS England has set for developing a commissioning policy for the Everolimus drug.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	11615
answer	answer is ministerial correction date of answer 16/10/2015 answer text <p>NHS England is currently developingtwo policies for the provision of Everolimus – one for the Tuberous Sclerosis forComplex Related Renal Angiomyolipoma andone for SubependymalGiant Cell Astrocytoma (SEGA). This was communicated to the National Health Service in a Specialised Services Circular on 2 July 2015.</p><p>These two policies will both be considered as in-year items for the specialised services work programme for 2015/16- however, a timetable for publication has not yet been agreed.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/10/2015 13:26:49 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

421098

registered interest
date	13/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Morquio Syndrome: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects NICE to publish its final guidance on the Vimizim treatment.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	11559
answer	answer is ministerial correction date of answer 16/10/2015 answer text <p>The National Institute for Health and Care Excellence currently expects to publish its final guidance on elosulfase alfa (Vimizim) for mucopolysaccharidosis (type IVA) or Morquio Syndrome in December 2015.</p><p><strong></strong></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/10/2015 11:39:27 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland